Abstract The US Preventive Services Task Force recommends patient-physician discussions about the appropriateness of colorectal cancer (CRC) screening among adults ages 76-84 years who have never been screened. In this study, we used data from the 2010 National Health Interview Survey to examine patterns of CRC screening and provider recommendation among seniors ages 76-84 years, and made some comparisons to younger adults. Nationally-representative samples of 1379 adults ages 76-84 years and 8797 adults ages 50-75 years responded to questions about CRC screening status, receipt of provider recommendation, and discussion of test options; 22.7 % (95 % CI 20.1-25.3) of seniors ages 76-84 had never been tested for CRC and therefore were not upto-date with guidelines; 3.9 % (95 % CI 2.0-7.6) of these individuals reported a recent provider recommendation for screening. In multivariate analyses, the likelihood of never having been tested was significantly greater for seniors of other/multiple race or Hispanic ethnicity; with high school or less education; without private health insurance coverage; who had B1 doctor visit in the past year; without recent screening for breast, cervical, or prostate cancer; with no or unknown CRC family history; or with B1 chronic disease. Among the minority of respondents ages 50-75 and 76-84 reporting a provider recommendation, 73.2 % indicated that the provider recommended particular tests, which was overwhelmingly colonoscopy (C89 %). Nearly one-quarter of adults 76-84 have never been screened for CRC, and rates of provider recommendation in this group are very low. Greater attention to informed CRC screening discussions with screening-eligible seniors is needed.
Introduction
Colorectal cancer (CRC) is the third most commonly diagnosed cancer in the United States and the second leading cause of cancer deaths [1, 2] . The elderly are disproportionately affected by CRC, as incidence doubles in each succeeding decade of life between the ages of 40 and 80 [3] . The increasing incidence rate is important because the elderly population in the United States is growing. In 2012, more than 18 million people were ages 75 or older, representing 5.9 % of the US population [4] . This cohort of seniors is expected to rapidly increase in the near future and to represent 19.3 % of the population by 2030, principally because of the aging of the ''baby boom'' generation. At age 75 years, average life expectancy is 11.7 years, with men having a slightly shorter life expectancy (10.6 years) than women (12.5 years) [5] .
Evidence has shown that CRC mortality can be reduced through screening. However, guidelines from expert groups vary in their recommendations for CRC screening in elderly individuals. The US Preventive Services Task Force (USPSTF) has given its strongest ('A') recommendation for routine CRC screening in average-risk adults ages 50-75 years [6] . It does not recommend screening individuals who are 85 years or older because the benefits of screening are unlikely to outweigh the harms. Although the USPSTF recommends against routine screening in individuals 76-84 years who have an adequate screening history, it also indicates that adults in this age group who have not previously been screened should be evaluated to determine whether screening is appropriate for them. The Multisociety Task Force does not place an upper age limit on its CRC screening recommendations [7] . More recent guidelines published by the American College of Physicians recommend that clinicians cease CRC screening in adults older than 75 years and in those with a life expectancy shorter than 10 years [8] .
Primary care physicians (PCPs) have a central role in delivering CRC screening. A recommendation from a health care provider has been shown to be a powerful and consistent influence on CRC screening uptake [9] . Guidelines state that PCPs should identify eligible patients, discuss available options with them, and facilitate successful completion of the selected screening option [6] [7] [8] . Yet, studies have shown that preventive services, such as CRC screening, are not always provided efficiently and effectively in primary care. For example, both underuse and overuse of CRC screening in the elderly have been documented [10] [11] [12] [13] . Provider-related barriers to recommending CRC screening include inadequate PCP knowledge of CRC screening guidelines; lack of time, training, and/or office supports for screening discussions in busy clinical settings; emphasis of many PCPs on colonoscopy as the only screening option discussed; and lack of practice-level strategies for facilitating CRC screening, such as use of reminder systems, performance reports, electronic health records, and non-physician clinicians [14] [15] [16] [17] . Addressing CRC screening in elderly patients may be particularly challenging for PCPs because of the need to weigh potential harms and benefits of screening within the context of seniors' comorbid medical conditions [1] .
A sizable literature has examined CRC screening uptake among US adults ages 50-75 [18] [19] [20] [21] . Much less attention has been given to those ages 76-84 years. In this paper, we characterize CRC screening status among US seniors ages 76-84. We also describe the extent to which unscreened adults in this age group report having received a health care provider recommendation for CRC screening, and whether providers recommended particular tests. Where appropriate, we compare the experiences of adults in the 76-84 age group with those ages 50-75 [18] . Our analysis is intended to provide insights about the screening-eligible population ages 76-84 that could be used to inform strategies to facilitate patient-centered discussions about CRC screening.
Methods

Data Source
The NHIS is an in-person, nationwide household survey of a representative sample of the US civilian, non-institutionalized population, 18 years of age and older, conducted annually by the National Center for Health Statistics of the Centers for Disease Control and Prevention (CDC). The 2010 Cancer Control Supplement to the NHIS was cosponsored by the National Cancer Institute's Division of Cancer Control and Population Sciences and CDC's Division of Cancer Prevention and Control. It asked respondents ages 40-84 about their CRC screening practices, including whether they had had sigmoidoscopy, colonoscopy, blood stool or occult blood testing (FOBT), or CT colonography/ virtual colonoscopy, and if so, when and why they received the test. Brief descriptions of each test were provided. Respondents who had not had a home FOBT in the past year, sigmoidoscopy in the past 5 years, colonoscopy in the past 10 years, or CT colonography in the past 5 years were asked whether, in the past 12 months, a doctor or other health professional recommended that they be tested to look for problems in their colon or rectum. Those responding ''yes'' were asked whether any particular tests were recommended, and which tests. Full survey instrumentation is available at: http://www.cdc.gov/nchs/nhis/nhis_questionnaires.htm. The response rate for the 2010 NHIS, taking into account household nonresponse, was 60.8 %.
Measures
CRC Test Use
We classified respondents as being recently tested for CRC if they reported having a home FOBT in the past year, sigmoidoscopy in the past 5 years, colonoscopy in the past 10 years, or CT colonography in the past 5 years. Respondents who reported having one or more CRC screening tests, but not within recommended time intervals, were classified as having been tested, but not recently. Those who had never had any of the tests were classified as never tested. We considered individuals ages 76-84 in the ''never had CRC testing'' group to be not up-to-date with guidelines [6] .
Provider Recommendation for CRC Screening
Receipt of provider recommendation for CRC screening in the past 12 months was categorized as yes or no.
Race/Ethnicity
We categorized respondents based on their reported race into three groups: white, black, and other/multiple race. We used a separate measure of Hispanic ethnicity (yes/no).
Education
Educational attainment was based on the highest level of education achieved and categorized as bachelor's degree or more, some college or associate's degree, high school graduate, and not attaining a high school diploma.
Income
Similar to Shapiro et al. [18] , we categorized respondents based on their reported annual family income as \$35,000, $35,000-49,999, $50,000-74,999, and C$75,000. Multiple imputation was used to impute missing data for income questions (http://www.cdc.gov/nchs/nhis/2010impute dincome.htm).
Health Insurance
We developed two categories for type of health insurance: (1) private, and (2) public only (i.e., Medicaid, Medicare, other government-sponsored insurance) or no insurance. Respondents who reported Medicare plus private supplemental insurance were included in the ''private'' category; those with Medicare but no supplemental insurance were assigned to the ''public'' category.
Physician Visits
We used three categories to measure the respondent's number of visits to a doctor or other health professional in the past year: none, one, and two or more.
Receipt of Recent Pap Test, Mammogram, or PSA Test
Women were asked whether they had ever had a Pap test or mammogram and, if yes, when they received their most recent test. Men were asked whether they had ever received a PSA test and, if yes, how many they had received in the past 5 years. We created measures of recent Pap test (in the past 3 years), recent mammogram (in the past 2 years), and recent PSA test (one or more in the past 5 years), as well as a composite measure of recent receipt of one or more of these tests (yes/no/unknown).
Number of Chronic Diseases
Consistent with Han et al. [22] , we created a measure of the number of self-reported chronic diseases. Included conditions were hypertension, stroke, diabetes, and chronic heart, kidney, liver, and lung disease. We categorized the number of chronic diseases as none, one, two, and three or more.
Data Analysis
We used descriptive statistics to characterize respondents' CRC screening status, whether respondents not recently or never tested had received a provider recommendation for CRC screening in the past 12 months, and the types of tests recommended. Individuals reporting a personal history of CRC (n = 140) were excluded. We conducted these analyses for both the 50-75 and 76-84 age groups, so that we could compare results for respondents ages 76-84 with their younger counterparts. Among respondents ages 76-84, we examined receipt of provider recommendation in both the ''not recently'' and ''never tested'' groupseven though the former was excluded from our definition of not up-to-date with guidelines-to gain a comprehensive understanding of which seniors are receiving provider recommendations. Because the 76-84 age group had limited sample size and a very low proportion of individuals reporting a provider recommendation, we report results for the types of CRC tests recommended for the 50-75 and 76-84 age groups combined. In total, only 355 respondents in the combined age group reported a provider recommendation, and only 251 of these indicated that their health care provider had recommended particular CRC tests.
We used logistic regression modeling to examine whether particular sociodemographic, health care access, or health status characteristics were associated with ''never having been tested for CRC'' among respondents ages 76-84. The dependent variable in the model was a dichotomous measure of respondents who had never been tested versus those reporting recent testing. The odds ratios estimated by this model compared the odds of being in the ''never tested'' group with the odds of being in the ''recently tested'' group.
Survey responses were weighted to reflect the probability of selection into the sample and survey nonresponse; the weighted data yield national estimates of the prevalence of CRC test use and receipt of provider recommendation. All analyses were conducted using SUDAAN release 10.0.1 (Research Triangle Institute, Research Triangle Park, NC). 
Results
Respondent Characteristics and CRC Screening Status
The sociodemographic, health care access, and health status characteristics of 1379 respondents ages 76-84 are shown in Table 1 . Among respondents ages 76-84, 64.0 % (95 % CI 60.9-66.9) were recently tested, 13.4 % (95 % CI 11.2-16.0) had been tested, but not recently, and 22.7 % (95 % CI 20.2-25.3) had never been tested and therefore were not up-todate with guidelines (Fig. 1a) In adjusted analyses, sociodemographic, health care access, and health status characteristics were all associated with never having been tested for CRC among seniors ages 76-84 (vs. recently tested) ( Table 3) . Seniors of other/multiple race or Hispanic ethnicity were more likely to have never been tested, as were those with high school or less education. Seniors with public only or no health insurance were more likely to have never been tested compared with those with private insurance coverage. Those who had no or only one physician office visit in the past year were more likely to have never been tested compared with seniors who had two or more visits. Seniors who had not received a recent Pap test, mammogram, or PSA test were more likely to never have been tested. Those reporting no family history of CRC or that they did not know their family history were more likely to never have been tested, as were those with one or no chronic disease.
Health Care Provider Recommendations to Adults Not Recently Tested for CRC
Overall, among US seniors ages 76-84 who were not recently or had never been tested for CRC, 5.9 % (95 % CI 3.9-8.9) reported receiving a provider recommendation for screening in the past 12 months (data not shown). In the tested but not recently group, 9.3 % (95 % CI 5.4-15.7) reported a provider recommendation; in the never tested group, 3.9 % (95 % CI 2.0-7.6) reported a provider recommendation (Fig. 1b) . These proportions were slightly lower than for the 50-75 age group, but were not statistically significantly different.
Types of CRC Screening Tests Recommended by Health Care Providers
Overall, 9 % of respondents ages 50-84 not recently or never tested for CRC reported receiving a provider recommendation for screening in the past 12 months. Of these respondents, nearly three-quarters (73.2 %) indicated that the provider recommended particular tests (Table 4 ). The specific test recommended was overwhelmingly colonoscopy (88.8 % colonoscopy only; an additional 1.8 % recommended both colonoscopy and FOBT). About 8 % of respondents reported that their provider recommended FOBT. Other tests, such as sigmoidoscopy and CT colonography, were mentioned by \3 % of respondents.
Discussion
The CRC screening status of seniors ages 76-84 in the US has received minimal attention, despite the burgeoning elderly population. Practice guidelines vary in their recommendations for CRC screening in this age group. Using nationally representative data, we found that 23 % of US adults ages 76-84-or about 2,155,000 people-have never been screened. We also found that seniors of other/multiple race or Hispanic ethnicity; less education; lacking private health insurance; with few or no physician visits; no recent screening for breast, cervical, or prostate cancer; no or unknown family history of CRC; or with one or no chronic disease were more likely to never have been screened. These results parallel studies of the 50-75 population that have shown particularly low CRC screening uptake among minorities, those with low socioeconomic status, and those lacking access to health care [18, 19] . Further, they illustrate that multi-level factors, such as personal demographics and health status and contact with the health care system, affect CRC screening status. We also found a very low rate of provider recommendation for screening (4 %) among seniors ages 76-84 who had never been tested. This was true as well for younger people (ages 50-75) who were not up-to-date with CRC screening. Moreover, in both age groups (adults ages 50-75 and ages 76-84), among those who reported receiving a provider recommendation for CRC screening but who had not recently or never been tested for CRC, colonoscopy was virtually the only test recommended. This finding is consistent with national data from PCPs indicating their favorable attitudes toward and preferences for colonoscopy [16] . A growing body of work shows that patients have preferences for CRC screening tests, and not all patients prefer colonoscopy, even though most PCPs favor this test [16, [23] [24] [25] [26] [27] . Some patients who receive only an offer of or recommendation for colonoscopy may choose not to get screened at all [28, 29] . Expert groups recommend that providers, particularly PCPs, undertake patient-centered discussions of CRC screening with eligible patients, and offer them options [6] [7] [8] .
The inclusion of national data on seniors ages 76-84 in our study is a novel contribution, and adds to the literature on population screening prevalence. Despite the fact that 25 % of all new CRC cases are diagnosed in this age group, few studies have assessed CRC screening in this population [30] . Discussions about CRC screening are particularly challenging in the elderly as there are considerations of comorbid conditions and remaining years of life, and screening tends to have less benefit and carry greater risks in older adults. [1, [31] [32] [33] . A recent analysis by Cho and colleagues attempted to shed light on this issue by examining comorbidity-adjusted life expectancy in a sample of Medicare beneficiaries ages 66 years and older [34] . Their analysis showed that older adults with higher levels of comorbidity had shorter life expectancies (approximately 3 years) than an average person of the same chronological age, and those with no comorbidities, even very elderly individuals, had longer life expectancies (approximately 3 years) than average adults of the same age. For an ''elderly'' individual with relatively low health-adjusted age, screening may be appropriate beyond his or her chronological age, thus making patient-centered discussions with PCPs all the more important as a strategy for improving CRC screening rates and reducing CRC morbidity and mortality.
Our study has limitations. Data are based on patient selfreports of screening status and provider recommendation, which may not be accurate. Additionally, NHIS items on health care provider discussions or recommendation of CRC screening were limited. Questions about the content and timing of discussions, patient knowledge of and preferences for test options, and patients' ratings of informed/ shared decision-making may be asked in future NHIS surveys. Future surveys could consider the periodicity of screening, in view of concerns about overscreening. Measurement of potential moderating variables also may have been limited. For example, our health insurance measure did not capture variability in coverage and co-payment requirements for CRC screening. We also did not investigate the potential influence of endoscopist availability on screening status and provider recommendation [35] . Finally, because of sample size limitations, we were unable to assess characteristics of respondents ages 76-84 who reported a recent health care provider recommendation for screening. Future work with another data source or an enhanced NHIS sample is needed to better understand CRC screening in the elderly.
In conclusion, we found that nearly one-quarter of seniors ages 76-84 have never been screened and therefore should be considered for CRC screening. We also found very low rates of provider recommendation for CRC screening among individuals in this age group as well as their younger 50-75 year-old counterparts who are not upto-date with CRC screening. PCPs should ascertain CRC screening status among patients ages 76-84 and initiate discussions about CRC screening with those who have never been tested, taking into account patient health status and life expectancy. Clearly, PCPs can play an important role in CRC control by systematically identifying eligible patients, promoting informed discussions about screening to confirm eligibility and appropriateness and to decide on best testing options, and tracking patients to ensure that CRC screening and follow-up are successfully completed. This key role of the PCP may be facilitated by adoption of a systems approach and systems strategies to promote successful incorporation of CRC screening into the preventive services offered to patients in primary care settings [17, [36] [37] [38] . 
